Iii Capital Management Biomarin Pharmaceutical Inc Call Options Transaction History

Iii Capital Management

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $2.05 Million - $2.37 Million	23,600 New	23,600 $2.05 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $28,592 - $34,740	400 New	400 $154,000
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $9,466 - $14,782	-119 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$71.37 - $96.85 $8,493 - $11,525	119 New	119 $42,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Iii Capital Management, based on Form 13F filings with the SEC.

Stay updated on Iii Capital Management with notifications on news.